| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 44.7387 | 26 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.6616 | 25 |
| GSM780709 | Untreated after 4 days (C3_1) | 44.4807 | 24 |
| GSM780719 | Untreated after 4 days (C1_2) | 43.5877 | 20 |
| GSM780720 | Untreated after 4 days (C2_2) | 47.5109 | 39 |
| GSM780721 | Untreated after 4 days (C3_2) | 42.8168 | 17 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 40.7768 | 9 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 40.4746 | 8 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.5293 | 30 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 44.6917 | 26 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 44.1149 | 23 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 37.6116 | 2 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.3769 | 15 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 41.4606 | 11 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.8253 | 17 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.4661 | 34 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.2068 | 23 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.6345 | 30 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.6242 | 30 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.6411 | 20 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.6602 | 40 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.8274 | 26 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.7848 | 31 |